ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $139 | -45.5% | 25,520 | -32.9% | 0.01% | -56.2% |
| Q2 2023 | $255 | -67.6% | 38,058 | -63.0% | 0.03% | -59.5% |
| Q4 2022 | $786 | -99.9% | 102,841 | +14.2% | 0.08% | +25.4% |
| Q3 2022 | $641,000 | -6.6% | 90,025 | +428.5% | 0.06% | -18.2% |
| Q1 2021 | $686,000 | – | 17,033 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,687,665 | $5,417,405 | 5.10% |
| Rubric Capital Management LP | 10,500,000 | $33,705,000 | 1.00% |
| Triatomic Management LP | 98,555 | $316,362 | 0.59% |
| Pier Capital, LLC | 1,103,441 | $3,542,046 | 0.49% |
| Newtyn Management, LLC | 623,690 | $2,002,045 | 0.40% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $96,279,803 | 0.36% |
| Matrix Capital Management Company, LP | 11,572,590 | $37,148,014 | 0.34% |
| Tejara Capital Ltd | 269,014 | $863,535 | 0.32% |
| Aristotle Atlantic Partners, LLC | 2,992,563 | $9,606,127 | 0.31% |
| DDD Partners, LLC | 739,739 | $2,374,562 | 0.29% |